← FDA Drug Approvals (Drugs@FDA)
LEVETIRACETAM IN SODIUM CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2023-01-31
Drug application
- FDA Application #
ANDA208619- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVETIRACETAM IN SODIUM CHLORIDE
- Generic name
- LEVETIRACETAM
- Active ingredients
- LEVETIRACETAM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Hp Halden Pharma AS
- First approval
- 2023-01-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown